I-Remdesivir Intermediate CAS 1354823-36-1 COVID-19 N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester

Incazelo emfushane:

N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester

I-CAS: 1354823-36-1

I-Intermediate ye-Remdesivir (CAS 1809249-37-3) yokwelashwa kwe-COVID-19

Ikhwalithi Ephezulu, Ukukhiqizwa Kwezohwebo

Inquiry: alvin@ruifuchem.com


Imininingwane Yomkhiqizo

Imikhiqizo Ehlobene

Omaka bomkhiqizo

Incazelo:

Chemical Properties:

Igama Lekhemikhali N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester
Omqondofana I-Remdesivir Intermediate;I-Remdesivir Side Chain;I-Remdesivir p-NitroPhenoxy L-Alanine Ukungcola;I-Remdesivir Ukungcola 4;I-Remdesivir-002;(S)-2-Ethylbutyl 2-((S)-(4-nitrophenoxy)(phenoxy)-phosphoryl)-amino)propanoate
Inombolo ye-CAS 1354823-36-1
Inombolo yeCAT I-RF-PI297
Isimo Sesitoko Esitokweni, Isikali Sokukhiqiza Sifika Emakhulwini Amakhilogremu
I-Molecular Formula I-C21H27N2O7P
Isisindo samangqamuzana 450.42
Ibhrendi I-Ruifu Chemical

Imininingwane:

Into Imininingwane
Ukubukeka Impushana Emhlophe Kuya Kucishe Emhlophe
Ukuhlonza IR, HPLC
Ukulahlekelwa Ekumisweni ≤1.0%
Ukungcola Okukodwa ≤0.50%
Izinsimbi Ezisindayo ≤20ppm
Ubumsulwa ≥98.0%
Izinga Lokuhlola I-Enterprise Standard
Ukusetshenziswa I-Intermediate ye-Remdesivir (CAS 1809249-37-3);I-COVID 19

Iphakheji nesitoreji:

Iphakheji: Ibhodlela, isikhwama se-Aluminium foil, isigubhu seCardboard, 25kg/Drum, noma ngokwezidingo zekhasimende.

Isimo Sesitoreji:Gcina ezitsheni ezivaliwe endaweni epholile neyomile;Vikela ekukhanyeni, umswakama kanye nezinambuzane.

Izinzuzo:

1

I-FAQ:

Isicelo:

I-N-[(S)-(4-nitrophenoxy)phenoxyphosphinyl]-L-Alanine 2-ethylbutyl ester (CAS 1354823-36-1, eyaziwa nangokuthi i-Remdesivir Ukungcola 4) i-sidechain ye-phosphoramidate ngokuvamile esetshenziselwa ukulungiswa kwe-Remdesivir (CAS 1809249-37-3, GS-5734), okuwumuthi ophenywayo we-antiviral inoveli owaqala ukwelapha isifo segciwane le-Ebola kanye nokutheleleka ngegciwane le-Marburg futhi okubuye kwatholakala ukuthi ukhombisa umsebenzi wokulwa namagciwane ngokumelene nama-coronavirus (isb. SARS-Cov-2/ I-COVID-19).Ngesikhathi sokuqubuka kwesifo esisha seCoronavirus sika-2019 (COVID-19), i-Remdesivir (CAS 1809249-37-3) ingomunye wemikhiqizo yocwaningo ehlobene ne-COVID-19.I-Remdesivir, ethengiswa ngaphansi kwegama lomkhiqizo i-Veklury, umuthi ovimbela amagciwane obanzi owenziwe yinkampani ye-biopharmaceutical Gilead Sciences.Ilawulwa ngomjovo emithanjeni.Ngesikhathi sobhubhane lwe-COVID-19, i-Remdesivir yagunyazwa noma yagunyazwa ukusetshenziswa okuphuthumayo ukwelapha i-COVID-19 emazweni acishe abe ngu-50.Imihlahlandlela ebuyekeziwe evela ku-World Health Organization ngoNovemba 2020 ihlanganisa isincomo esinemibandela ngokumelene nokusetshenziswa kwe-Remdesivir ekwelapheni i-COVID-19.

Bhala umyalezo wakho lapha futhi usithumelele wona